Breast Cancer with Palb2 Mutation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-08-22
Clinical Trial Update: Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer [Phase 1]
This clinical trial update describes a Phase Ib study evaluating Axatilimab in combination with Olaparib for BRCA1/2- and PALB2-associated m…